(Q47405665)

15 January 2018

title

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. (English)

1 reference

15 January 2018

author

Randy J. Seeley

6

1 reference

15 January 2018

Stephen C. Woods

4

object named as

Stephen C Woods

1 reference

15 January 2018

author name string

April D Strader

1

1 reference

15 January 2018

Torsten P Vahl

2

1 reference

15 January 2018

Ronald J Jandacek

3

1 reference

15 January 2018

David A D'Alessio

5

1 reference

15 January 2018

publication date

28 September 2004

1 reference

15 January 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

15 January 2018

volume

288

1 reference

15 January 2018

issue

2

1 reference

15 January 2018

page(s)

E447-53

1 reference

15 January 2018

Roux-en-Y gastric bypass for morbid obesity

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Bariatric surgery and long-term control of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Gastrointestinal factors in hunger and satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

A novel, noninvasive method for the measurement of intestinal fat absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Internal signals cause large changes in food intake in one-way crossed intestines rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Preservation of intestinal structure and function despite weight loss produced by ileal transposition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Current status of medical and surgical therapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

The gut and food intake: an update for surgeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Etiology of type II diabetes mellitus: role of the foregut

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

21 January 2018

The Epidemic of Obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

Ileal release of glucagon-like peptide-1 (GLP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

GLP-1 does not acutely affect insulin sensitivity in healthy man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00153.2004

10.1152/AJPENDO.00153.2004

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

15454396

1 reference

15 January 2018